Acadian Asset Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-11
Closed 1697
2024
Q4
$0 Sell
11
-3,563
-100% ﹤0.01% 1833
2024
Q3
$59K Sell
3,574
-1,774
-33% -$29.3K ﹤0.01% 1749
2024
Q2
$150K Buy
5,348
+2,043
+62% +$57.3K ﹤0.01% 1480
2024
Q1
$991K Sell
3,305
-2,107
-39% -$632K ﹤0.01% 842
2023
Q4
$1.28M Sell
5,412
-3,029
-36% -$714K ﹤0.01% 791
2023
Q3
$1.27M Sell
8,441
-3,056
-27% -$458K 0.01% 808
2023
Q2
$2M Sell
11,497
-2,520
-18% -$438K 0.01% 688
2023
Q1
$1.77M Sell
14,017
-5,414
-28% -$682K 0.01% 740
2022
Q4
$5.89M Sell
19,431
-470
-2% -$142K 0.03% 401
2022
Q3
$1.1M Hold
19,901
0.01% 782
2022
Q2
$1.19M Hold
19,901
0.01% 775
2022
Q1
$2.27M Buy
19,901
+390
+2% +$44.4K 0.01% 643
2021
Q4
$2.81M Buy
19,511
+650
+3% +$93.5K 0.01% 577
2021
Q3
$4.13M Sell
18,861
-656
-3% -$144K 0.02% 498
2021
Q2
$4.53M Buy
19,517
+3,064
+19% +$711K 0.02% 490
2021
Q1
$4.95M Buy
16,453
+8,356
+103% +$2.51M 0.02% 482
2020
Q4
$3.04M Buy
8,097
+3,787
+88% +$1.42M 0.01% 631
2020
Q3
$1.32M Buy
4,310
+1,651
+62% +$507K 0.01% 797
2020
Q2
$1M Buy
2,659
+2,625
+7,721% +$987K ﹤0.01% 962
2020
Q1
$8K Hold
34
﹤0.01% 1714
2019
Q4
$18K Sell
34
-130
-79% -$68.8K ﹤0.01% 1729
2019
Q3
$71K Buy
+164
New +$71K ﹤0.01% 1557
2016
Q4
Sell
-5
Closed -$4K 1681
2016
Q3
$4K Sell
5
-248
-98% -$198K ﹤0.01% 1334
2016
Q2
$183K Buy
253
+232
+1,105% +$168K ﹤0.01% 946
2016
Q1
$12K Buy
+21
New +$12K ﹤0.01% 1163
2015
Q3
Sell
-17
Closed -$14K 1346
2015
Q2
$14K Hold
17
﹤0.01% 1114
2015
Q1
$14K Buy
+17
New +$14K ﹤0.01% 1150